In a bold move, Medtronic, a global healthcare technology leader, has taken significant steps to expand its robotic-assisted surgery (RAS) system, Hugo™, into new specialties in the United States. This announcement, made on June 3, 2026, showcases Medtronic's commitment to revolutionizing surgery and shaping the future of healthcare.
Unlocking New Possibilities
Medtronic's recent actions are a testament to their innovative spirit and dedication to improving patient care. By submitting 510(k) filings, they aim to expand the Hugo™ RAS system's capabilities beyond urologic procedures, which it was initially cleared for in 2025. Now, the system is poised to make a significant impact in general and gynecologic surgeries, addressing the growing demand for minimally invasive robotic-assisted options in these high-volume specialties.
Advancing Surgical Technology
One of the key milestones is the submission of a 510(k) filing for the LigaSure™ RAS Maryland instrument. This instrument, designed exclusively for the Hugo™ RAS system, incorporates vessel-sealing technology that has been trusted in over 35 million procedures worldwide. Integrating this technology onto the RAS platform is a game-changer, providing surgeons with enhanced control and confidence during complex procedures.
Additionally, Medtronic has received FDA clearance for ProGrip™ Advanced, an advanced mesh technology specifically designed for robotic-assisted ventral hernia repair. ProGrip™ Advanced offers improved surgical efficiency, ease of use, and a range of sizes to cater to individual patient needs. With nearly 470,000 ventral hernia repair procedures performed annually in the U.S., the demand for robotic assistance is growing, and Medtronic's innovative mesh technology is well-positioned to meet this need.
Embracing Gynecologic Care
Medtronic's commitment to gynecologic care is evident in their completion of enrollment for the Embrace Gynecology IDE clinical study. This prospective multicenter study aims to evaluate the safety and effectiveness of the Hugo™ RAS system in robotic-assisted gynecologic procedures. By enrolling 70 patients across 5 U.S. hospitals, Medtronic is taking a significant step towards expanding access to advanced surgical options for gynecologic patients.
A Holistic Surgical Ecosystem
What makes Medtronic's approach particularly fascinating is their ability to offer a comprehensive surgical ecosystem. They are the first and only company to provide solutions across all surgical modalities—open, laparoscopic, and robotic-assisted. This holistic approach gives surgeons and healthcare systems the flexibility and partnership needed to develop successful surgery programs tailored to various care settings.
The Future of Surgery
Medtronic's milestones and innovative technologies are not just about expanding their portfolio; they represent a deeper commitment to uniting instruments, intelligence, and human hands into a unique surgical ecosystem. As Dr. Matthew Kroh, Medtronic's chief medical officer, puts it, "As more and more surgeons and patients demand robotic-assisted surgery, we need more access to technology and training, and Medtronic brings that choice in a very powerful way."
In my opinion, Medtronic's vision for the future of surgery is inspiring. By continuously enhancing their RAS system and collaborating with surgical teams globally, they are driving surgical innovation and ensuring that every patient, everywhere, has access to the best possible surgery. This is a bold and ambitious goal, and I believe Medtronic is well on its way to making it a reality.
